GALT icon

Galectin Therapeutics
GALT

Overview Fund Activity

70 hedge funds and large institutions have $28.2M invested in Galectin Therapeutics in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 23 reducing their positions, and 14 closing their positions.

Holders
70
Holders Change
-5
Holders Change %
-6.67%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
12
Reduced
23
Closed
14
Calls
$2.84M
Puts
$1.23M
Net Calls
+$1.61M
Net Calls Change
+$551K

Top Buyers

1
Geode Capital Management
1
Geode Capital Management
Massachusetts
$2.1M
2
KeyBank National Association
2
KeyBank National Association
Ohio
$388K
3
Capstone Investment Advisors
3
Capstone Investment Advisors
New York
$164K
4
QAM
4
QCI Asset Management
New York
$213K
5
Citadel Advisors
5
Citadel Advisors
Florida
$95K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$39K
2
Millennium Management
2
Millennium Management
New York
$1.36M
3
TEE
3
Tibra Equities Europe
United Kingdom
$0
4
Marshall Wace
4
Marshall Wace
United Kingdom
$0
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$389K
Name Holding Trade Value Shares
Change 		Shares
Change %
Jane Street
76
Jane Street
New York
– -$36K -11,133 Closed
BFM
77
Boothbay Fund Management
New York
– -$35K -10,965 Closed
PCM
78
Pinz Capital Management
New York
– -$20K -6,300 Closed
OSAM
79
O'Shaughnessy Asset Management
Connecticut
– -$18K -5,655 Closed
Citigroup
80
Citigroup
New York
– -$2K -557 Closed
New York State Common Retirement Fund
81
New York State Common Retirement Fund
New York
– -$1K -259 Closed
CAPTRUST Financial Advisors
82
CAPTRUST Financial Advisors
North Carolina
– -$1K -213 Closed
1 2 3
4